NCT06815796

Brief Summary

The goal of this clinical trial is to learn if loop tenodesis is as effective as suture anchor tenodesis for treating long head of biceps (LHB) pathology. It will also assess the safety and outcomes of both techniques. The main questions it aims to answer are: How effective is loop tenodesis compared to suture anchor tenodesis in preventing shoulder deformities and maintaining biomechanical strength? What complications or failures occur with each technique? Researchers will compare suture anchor tenodesis using the Arthrex FiberTak system with loop tenodesis (an implant-free technique). Participants will: Undergo surgery with either suture anchor tenodesis or loop tenodesis, assigned randomly. Be informed about the procedure and sign a consent form prior to surgery. Have their clinical outcomes evaluated and compared before and after their treatment.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 1, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 7, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

February 7, 2025

Status Verified

February 1, 2025

Enrollment Period

1.7 years

First QC Date

December 1, 2024

Last Update Submit

February 6, 2025

Conditions

Keywords

Biceps Tendon PathologyArthroscopic TenodesisLoop TenodesisSuture Anchor TenodesisClinical outcomesReturn to sport

Outcome Measures

Primary Outcomes (3)

  • Constant-Murley Score

    score ranges from 0 to 100 points, representing worst and best shoulder function

    up to 24 months

  • American Shoulder and Elbow Surgeons score (ASES)

    ranges from 0 to 100, with 0 the lowest level of function and 100 the highest level of function

    up to 24 months

  • Disabilities of the arm, shoulder and hand (DASH) outcome questionnaire

    scored 0 (no disability) to 100

    up to 24 months

Secondary Outcomes (10)

  • Cosmetic Outcome

    up to 24 months

  • Strength

    up to 24 months

  • Complications

    up to 24 months

  • Pain (pre-/postOP)

    up to 24 months

  • Sport activities

    up to 24 months

  • +5 more secondary outcomes

Study Arms (2)

Loop tenodesis of Long head of biceps tendon

EXPERIMENTAL

Long head of biceps tenodesis using loop technique

Procedure: Arthroscopic Loop tenodesis of long head of biceps.

Anchor tenodesis of Long head of biceps tendon

ACTIVE COMPARATOR

Long head of biceps tenodesis using anchor technique

Procedure: Anchor Tenodesis of Long head of biceps tendon

Interventions

Loop tenodesis of the long head of biceps tendon.

Loop tenodesis of Long head of biceps tendon

Anchor Tenodesis of Long head of biceps tendon

Anchor tenodesis of Long head of biceps tendon

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All patients requiring a tenodesis of the long head of the biceps tendon during the study period, using either anchor tenodesis or loop tenodesis.
  • Patients must be at least 18 years old.
  • Patients must have the capacity to give informed consent.

You may not qualify if:

  • Patients with insufficient documentation.
  • Patients under the age of 18.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ordensklinikum Linz Barmherzige Schwestern

Linz, 4020, Austria

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized allocation to 2 groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2024

First Posted

February 7, 2025

Study Start

January 1, 2023

Primary Completion

August 31, 2024

Study Completion

April 30, 2025

Last Updated

February 7, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

IPD can be shared upon request, due to government privacy policy routine uploading of specific data can not be done.

Locations